Colombian singer Maluma pauses concert to address mother bringing one-year-old baby without ear protection, emphasizing child safety at events.
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Jellyfish swarm forces temporary shutdown of four reactors at France's Gravelines nuclear plant, highlighting climate change's impact on coastal infrastructure.
Colombian singer Maluma pauses concert to address mother bringing one-year-old baby without ear protection, emphasizing child safety at events.
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Jellyfish swarm forces temporary shutdown of four reactors at France's Gravelines nuclear plant, highlighting climate change's impact on coastal infrastructure.